Minerva Neurosciences (NASDAQ:NERV) Stock Crosses Below Fifty Day Moving Average – Here’s Why

by · The Cerbat Gem

Shares of Minerva Neurosciences, Inc. (NASDAQ:NERV – Get Free Report) crossed below its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of $2.33 and traded as low as $2.13. Minerva Neurosciences shares last traded at $2.14, with a volume of 16,335 shares trading hands.

Wall Street Analyst Weigh In

Several brokerages have recently issued reports on NERV. StockNews.com initiated coverage on shares of Minerva Neurosciences in a research note on Friday. They issued a “sell” rating on the stock. HC Wainwright restated a “neutral” rating and issued a $5.00 target price on shares of Minerva Neurosciences in a report on Wednesday, November 6th.

Get Our Latest Stock Report on NERV

Minerva Neurosciences Stock Up 0.9 %

The firm’s 50-day moving average price is $2.32 and its two-hundred day moving average price is $2.74. The firm has a market capitalization of $15.10 million, a PE ratio of -4.91 and a beta of 0.11.

About Minerva Neurosciences

(Get Free Report)

Minerva Neurosciences, Inc, a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone (MIN-101) for the treatment of negative symptoms in patients with schizophrenia, currently submitted an New Drug Application (NDA); and MIN-301, a soluble recombinant form of the neuregulin-1b1 protein for the treatment of Parkinson's disease and other neurodegenerative disorders.

Read More